These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9543473)

  • 21. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus.
    Fritsche TR; Jones RN
    J Drugs Dermatol; 2005; 4(6 Suppl):s4-8. PubMed ID: 16300223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the properties that make an antibiotic acceptable for therapy of community-acquired pneumonia?
    Drusano GL
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii61-7. PubMed ID: 21482571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Community acquired pneumonia; no reason to revise current Dutch antibiotic guidelines].
    Oosterheert JJ; Bonten MJ; Schneider MM; Hoepelman IM
    Ned Tijdschr Geneeskd; 2003 Mar; 147(9):381-6. PubMed ID: 12661455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of pneumonia acquired in the community].
    Waschbisch T; Schlesser M; Nati R
    Bull Soc Sci Med Grand Duche Luxemb; 2002; (2):121-34. PubMed ID: 12664656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment.
    Hedrick J
    Paediatr Drugs; 2003; 5 Suppl 1():35-46. PubMed ID: 14632104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy.
    Bartlett JG
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment and course of community-acquired pneumonia caused by atypical pathogens].
    Fernández Alvarez R; Suárez Toste I; Rubinos Cuadrado G; Medina Gonzálvez A; Gullón Blanco JA; González Martín I
    Arch Bronconeumol; 2006 Sep; 42(9):430-3. PubMed ID: 17040657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microbiological diagnostic and antibiotic management of community aquired and nosocomial pneumonias in intensive care units in Germany].
    Meyer E; Ebner W; Heininger A; Schwab F; Rüden H; Daschner FD
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Feb; 40(2):85-90. PubMed ID: 15714398
    [No Abstract]   [Full Text] [Related]  

  • 33. In-hospital management of adults who have community-acquired pneumonia.
    Ortqvist A
    Semin Respir Infect; 1999 Jun; 14(2):135-50. PubMed ID: 10391408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
    File TM; Benninger MS; Jacobs MR
    Clin Lab Med; 2004 Jun; 24(2):531-51. PubMed ID: 15177852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia also applicable in The Netherlands].
    van den Broek PJ; Bohte R
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2200; author reply 2201-2. PubMed ID: 9550805
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia.
    Bhavnani SM; Forrest A; Hammel JP; Drusano GL; Rubino CM; Ambrose PG
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):99-101. PubMed ID: 18583085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of pneumonia in a community].
    Lecocq P; Mouton Y
    Rev Prat; 1993 Feb; 43(4):475-9. PubMed ID: 8341915
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of community-acquired pneumonia in an ambulatory setting.
    Butt S; Swiatlo E
    Am J Med; 2011 Apr; 124(4):297-300. PubMed ID: 21435417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.
    Brown RB; Iannini P; Gross P; Kunkel M
    Chest; 2003 May; 123(5):1503-11. PubMed ID: 12740267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Start treatment of community-acquired pneumonia in outpatients and in hospitalized patients].
    Budanov SV
    Antibiot Khimioter; 2001; 46(10):25-34. PubMed ID: 11881190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.